CLINICAL TRIALS PROFILE FOR FLECAINIDE ACETATE
✉ Email this page to a colleague
All Clinical Trials for FLECAINIDE ACETATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00002996 ↗ | Flecainide in Treating Patients With Chronic Neuropathic Pain | Completed | National Cancer Institute (NCI) | Phase 2 | 1998-02-01 | RATIONALE: Flecainide therapy may help patients with neuropathic pain live more comfortably. PURPOSE: Phase II trial to study the effectiveness of flecainide in treating patients with chronic neuropathic pain from cancer or AIDS. |
NCT00002996 ↗ | Flecainide in Treating Patients With Chronic Neuropathic Pain | Completed | Eastern Cooperative Oncology Group | Phase 2 | 1998-02-01 | RATIONALE: Flecainide therapy may help patients with neuropathic pain live more comfortably. PURPOSE: Phase II trial to study the effectiveness of flecainide in treating patients with chronic neuropathic pain from cancer or AIDS. |
NCT00189319 ↗ | To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation | Completed | MEDA Pharma GmbH & Co. KG | Phase 4 | 2003-09-01 | The purpose of this study is to evaluate the management of paroxysmal atrial fibrillation with controlled release flecainide on patient's quality of life. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for FLECAINIDE ACETATE
Condition Name
Clinical Trial Locations for FLECAINIDE ACETATE
Trials by Country
Clinical Trial Progress for FLECAINIDE ACETATE
Clinical Trial Phase
Clinical Trial Sponsors for FLECAINIDE ACETATE
Sponsor Name